preSABATO pilot study: Antimicrobial therapy of uncomplicated Staphylococcus aureus Bacteremia

• Conditions: A41.0; A49.0; Sepsis due to Staphylococcus aureus; Staphylococcal infection, unspecified site

• Registration Number: DRKS00000062
• Lead Sponsor: Institut für medizinische Mikrobiologie,Immunologie und HygieneUniklinik Köln

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2009-02-02
• Study Completion: 2010-09-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 258

Inclusion Criteria

S. aureus Bacteremia

Exclusion Criteria

none

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Crude mortality

Secondary Outcome Measures

Name	Time	Method
umber of patients with late complications of S. aureus bacteremia<br><br>Number of recruitable patients with S. aureus bacteremia